Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens
Open Access
- 1 July 1998
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 41 (7) , 1152-1160
- https://doi.org/10.1002/1529-0131(199807)41:7<1152::aid-art3>3.0.co;2-l
Abstract
No abstract availableThis publication has 85 references indexed in Scilit:
- The transcriptional activator Sp1, a novel autoantigenArthritis & Rheumatism, 1997
- Antineutrophil Cytoplasmic Autoantibodies Interact with Primary Granule Constituents on the Surface of Apoptotic Neutrophils in the Absence of Neutrophil PrimingThe Journal of Experimental Medicine, 1996
- Protein Degradation or Regulation: Ub the JudgeCell, 1996
- Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patientsJournal of Clinical Laboratory Analysis, 1996
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995
- Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice.The Journal of Experimental Medicine, 1994
- Negative selection of lymphocytesCell, 1994
- The spontaneous apoptotic cell death of normal human lymphocytes in vitro: The release of, and immunoproliferative response to, nucleosomes in vitroClinical Immunology and Immunopathology, 1991
- Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative DiseaseAnnual Review of Immunology, 1991
- Probing the Human B-Cell Repertoire with EBV: Polyreactive Antibodies and CD5+ B LymphocytesAnnual Review of Immunology, 1989